Neurobiological Technologies, Inc.
NTII · OTC
9/30/2009 | 6/30/2009 | 3/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $8 | $6 | $7 |
| Short-Term Investments | $17 | $16 | $16 | $16 |
| Receivables | $3 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $30 | $25 | $22 | $24 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $7 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $9 |
| Total NC Assets | $0 | $0 | $7 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $25 | $29 | $33 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $6 | $6 |
| Other Curr. Liab. | $1 | $1 | $6 | $8 |
| Total Curr. Liab. | $1 | $1 | $12 | $14 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $9 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $11 |
| Total NC Liab. | $0 | $0 | $9 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1 | $1 | $21 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$117 | -$122 | -$137 | -$136 |
| AOCI | $0 | $0 | -$1 | -$1 |
| Other Equity | $146 | $146 | $146 | $146 |
| Total Equity | $29 | $24 | $8 | $8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $25 | $29 | $33 |
| Net Debt | -$10 | -$8 | -$6 | -$7 |